Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway*
暂无分享,去创建一个
Elliott M. Ross | Robert A. Rebres | Lily I. Jiang | Dianne DeCamp | Iain Fraser | Ronald Taussig | Richard Davis | Julie Collins | Paul C. Sternweis | Robert Hsueh | Keng-Mean Lin | Tamara Roach
[1] T. Hla,et al. Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5* , 1999, The Journal of Biological Chemistry.
[2] G. Baillie,et al. The MAP kinase ERK2 inhibits the cyclic AMP‐specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 , 1999, The EMBO journal.
[3] G. Baillie,et al. ERK2 Mitogen-activated Protein Kinase Binding, Phosphorylation, and Regulation of the PDE4D cAMP-specific Phosphodiesterases , 2000, The Journal of Biological Chemistry.
[4] A. Wittinghofer,et al. Structure and regulation of the cAMP-binding domains of Epac2 , 2003, Nature Structural Biology.
[5] M. Conti,et al. Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase , 1995, The Journal of Biological Chemistry.
[6] V. Sah,et al. The role of Rho in G protein-coupled receptor signal transduction. , 2000, Annual review of pharmacology and toxicology.
[7] G. Milligan,et al. Tailoring cAMP-signalling responses through isoform multiplicity. , 1997, Trends in biochemical sciences.
[8] S. Kimura,et al. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. , 1999, The Biochemical journal.
[9] E. Goetzl,et al. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.
[10] J. Bos. Epac: a new cAMP target and new avenues in cAMP research , 2003, Nature Reviews Molecular Cell Biology.
[11] D. Manning,et al. Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. , 2002, Biochimica et biophysica acta.
[12] L. Brass,et al. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties. , 1992, The Biochemical journal.
[13] J. Beavo,et al. Cyclic nucleotide research — still expanding after half a century , 2002, Nature Reviews Molecular Cell Biology.
[14] Xiaodong Cheng,et al. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] Thomas A Luger,et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.
[16] G. Johnson,et al. Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly (*) , 1995, The Journal of Biological Chemistry.
[17] A. Gilman,et al. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. , 1991, Science.
[18] T. Ishizuka,et al. Comparison of Intrinsic Activities of the Putative Sphingosine 1-Phosphate Receptor Subtypes to Regulate Several Signaling Pathways in Their cDNA-transfected Chinese Hamster Ovary Cells* , 1999, The Journal of Biological Chemistry.
[19] R. Tsien,et al. Reducing the Environmental Sensitivity of Yellow Fluorescent Protein , 2001, The Journal of Biological Chemistry.
[20] D. Storm,et al. Calmodulin-regulated adenylyl cyclases: cross-talk and plasticity in the central nervous system. , 2003, Molecular pharmacology.
[21] Y. Yatomi,et al. EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.
[22] A. Miyawaki,et al. Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Bristow,et al. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. , 2005, Current topics in developmental biology.
[24] Madhusudan Natarajan,et al. A global analysis of cross-talk in a mammalian cellular signalling network , 2006, Nature Cell Biology.
[25] J. Beavo,et al. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.
[26] P. Epstein,et al. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. , 2006, The Biochemical journal.
[27] S. Pyne,et al. Sphingosine 1-phosphate signalling in mammalian cells , 2000 .
[28] A. Lania,et al. G protein mutations in endocrine diseases. , 2001, European journal of endocrinology.
[29] Martin J. Lohse,et al. Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation*♦ , 2004, Journal of Biological Chemistry.
[30] J. T. Turner,et al. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL. , 1992, The Journal of pharmacology and experimental therapeutics.
[31] A. Barr,et al. Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins* , 1999, The Journal of Biological Chemistry.
[32] Weng-Lang Yang,et al. Reinventing the Wheel of Cyclic AMP , 2002 .
[33] J. Hanoune,et al. Regulation and role of adenylyl cyclase isoforms. , 2001, Annual review of pharmacology and toxicology.
[34] K. Baltensperger,et al. Thrombin and phorbol esters potentiate Gs-mediated cAMP formation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII. , 1998, Molecular pharmacology.
[35] T. Issad,et al. The use of resonance energy transfer in high-throughput screening: BRET versus FRET. , 2002, Trends in pharmacological sciences.
[36] R. T. Miller,et al. Purification and characterization of the alpha subunit of G13. , 1994, The Journal of biological chemistry.
[37] R. Sunahara,et al. Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. , 2002, Molecular interventions.
[38] A. Sahu,et al. A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding , 2002, Nature Neuroscience.
[39] Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors , 2005, Medicinal research reviews.
[40] T. Ohmori,et al. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. , 2002, Biochemical and biophysical research communications.
[41] Kees Jalink,et al. Detecting cAMP‐induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator , 2004, EMBO reports.
[42] R. Stoffel,et al. A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. , 1995, Science.
[43] A. Wittinghofer,et al. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state , 2006, Nature.
[44] Ian McPhee,et al. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1) , 2002, British journal of pharmacology.
[45] T. Bleu,et al. Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.
[46] H. Rosen,et al. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.
[47] Susan S. Taylor,et al. A genetically encoded, fluorescent indicator for cyclic AMP in living cells , 1999, Nature Cell Biology.